Trial Profile
Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension, Hyperhomocysteinemia and Angiotension-Converting Enzyme Inhibitor Intolerance
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/folic-acid (Primary) ; Amlodipine
- Indications Essential hypertension; Hyperhomocysteinaemia
- Focus Therapeutic Use
- Sponsors Shenzhen Ausa Pharmed
- 15 Oct 2013 New trial record